Literature DB >> 25495291

Autopsy case of spinocerebellar ataxia type 31 with severe dementia at the terminal stage.

Tadashi Adachi1, Michio Kitayama1, Toshiya Nakano1, Yoshiki Adachi2, Shinsuke Kato3, Kenji Nakashima1.   

Abstract

Spinocerebellar ataxia type 31 (SCA31) is an autosomal dominant cerebellar ataxia commonly observed in Japan. However, few neuropathological examinations have been conducted. Here we report the case of a 76-year-old Japanese male SCA31 patient. He noticed dysarthria and difficulty walking at 65 years old. His symptoms subsequently deteriorated, although he could still walk with assistance at 70 years. At 73 years, when he could no longer walk, he was admitted to our hospital. He showed severe limb and truncal ataxia. His father and older brother had shown the same symptoms. Brain magnetic resonance imaging showed cerebellar atrophy of the anterior lobe and white matter hyperintensities. He was diagnosed with SCA31 by genetic analysis. Gradually, his cognitive functions and ability to communicate declined. He died of respiratory failure at the age of 76. Neuropathological examination revealed severe Purkinje cell loss that was accentuated in the anterior lobe of the cerebellum. Furthermore, the remaining Purkinje cells showed abnormal processes (that is, halo-like amorphous materials), as has been reported previously. Severe deposition of hyperphosphorylated tau-positive neurites, many senile plaques and amyloid angiopathy were observed in the neocortex. Our findings suggest that in SCA31, accelerated tau and amyloid pathology in the neocortex might induce dementia at the terminal stage.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  SCA31; autosomal dominant; dementia; pathology; tau

Mesh:

Year:  2014        PMID: 25495291     DOI: 10.1111/neup.12184

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  5 in total

1.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

2.  Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31.

Authors:  Yoshiaki Takahashi; Yasuhiro Manabe; Ryuta Morihara; Hisashi Narai; Toru Yamashita; Koji Abe
Journal:  Case Rep Neurol       Date:  2017-05-17

3.  Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction.

Authors:  Ryohei Norioka; Keizo Sugaya; Aki Murayama; Tomoya Kawazoe; Shinsuke Tobisawa; Akihiro Kawata; Kazushi Takahashi
Journal:  Cerebellum Ataxias       Date:  2021-03-30

4.  Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22.

Authors:  Mengjie Li; Fen Liu; Xiaoyan Hao; Yu Fan; Jiadi Li; Zhengwei Hu; Jingjing Shi; Liyuan Fan; Shuo Zhang; Dongrui Ma; Mengnan Guo; Yuming Xu; Changhe Shi
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

5.  The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia.

Authors:  Anna F Fusco; Angela L McCall; Justin S Dhindsa; Logan A Pucci; Laura M Strickland; Amanda F Kahn; Mai K ElMallah
Journal:  J Neuroinflamm Neurodegener Dis       Date:  2019-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.